Brazil - August 17 2021
A look at the key features of the merger control legislation in Brazil, including filing requirements, review thresholds and necessary regulatory approvals.
Vivian Fraga do Nascimento Arruda, Marcelo Calliari, Patricia Carvalho, Tatiana Lins Cruz, Mario Pati, Marcel Medon Santos
Brazil - February 23 2022
This article reviews the essential regulatory considerations surrounding medicines and medical devices in Brazil, including clinical trials and marketing authorisations.
Victor Hugo Callejon Avallone, Marco Aurélio Torronteguy
Brazil - August 17 2021
A brief overview of key procedures and practical considerations surrounding merger notification and clearance in Brazil, including timetables, documentation and sanctions for noncompliance.
Vivian Fraga do Nascimento Arruda, Marcelo Calliari, Patricia Carvalho, Tatiana Lins Cruz, Mario Pati, Marcel Medon Santos
Brazil - February 23 2022
An examination of the key legal and practical issues surrounding the pricing and reimbursement of medicinal products and medical devices in Brazil.
Victor Hugo Callejon Avallone, Marco Aurélio Torronteguy